Nuvation Bio NUVB Peer Comparison

NYSE NUVB
$6.85 +0.08 (+1.17%)
As of: Sep 4, 2026 · 2:22 PM EDT
Peer Comparison

300 Comparable Companies

Industry Pharmaceuticals

Nuvation Bio Inc. (NUVB) is the 124th largest of 300 Pharmaceuticals companies by market capitalisation, at 2.39 Bn, behind Viridian Therapeutics, Inc.\DE at 2.40 Bn. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 JNJ Johnson & Johnson primary H-01 Pharmaceuticals and Biotechnology HG-01 663.00 Bn 31.52 6.77 642.24 Bn
2 ABBV AbbVie Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 452.66 Bn 71.67 7.03 446.09 Bn
3 MRK Merck & Co., Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 371.61 Bn 117.26 5.58 364.47 Bn
4 NVS Novartis Ag primary H-01 Pharmaceuticals and Biotechnology HG-01 309.79 Bn 13.77 4.51 302.10 Bn
5 PFE Pfizer Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 162.45 Bn 37.19 2.55 150.75 Bn
6 SNY Sanofi primary H-01 Pharmaceuticals and Biotechnology HG-01 53.81 Bn 11.54 1.00 46.43 Bn
7 RVMD Revolution Medicines, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 44.07 Bn -24.92 — 44.07 Bn
8 ONC BeOne Medicines Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 39.99 Bn 60.99 6.52 34.89 Bn
9 INCY Incyte Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 25.64 Bn 15.90 4.41 21.11 Bn
10 UTHR UNITED THERAPEUTICS Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 20.84 Bn 15.90 6.61 18.18 Bn
11 NBIX Neurocrine Biosciences Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 15.71 Bn 22.27 4.66 15.32 Bn
12 JAZZ Jazz Pharmaceuticals plc primary H-01 Pharmaceuticals and Biotechnology HG-01 15.63 Bn 16.61 3.40 14.01 Bn
13 EXEL Exelixis, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 14.82 Bn 17.22 6.08 13.98 Bn
14 CORT Corcept Therapeutics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 11.79 Bn 217.60 14.20 11.49 Bn
15 KYMR Kymera Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 11.55 Bn -38.54 109.96 10.85 Bn
16 AXSM Axsome Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 10.71 Bn -69.64 13.79 10.39 Bn
17 GPCR Structure Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 10.28 Bn -54.65 — 10.28 Bn
18 NUVL Nuvalent, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 9.75 Bn -27.07 — 9.75 Bn
19 CYTK Cytokinetics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 9.59 Bn -13.07 141.69 8.42 Bn
20 CRNX Crinetics Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 8.99 Bn -17.90 213.22 8.99 Bn
21 ALKS Alkermes plc. primary H-01 Pharmaceuticals and Biotechnology HG-01 7.76 Bn 117.36 4.65 7.11 Bn
22 BLTE Belite Bio, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 6.25 Bn -81.06 — 6.25 Bn
23 TVTX Travere Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 6.14 Bn -141.15 10.37 6.14 Bn
24 LQDA Liquidia Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 6.11 Bn 44.09 13.55 5.83 Bn
25 AMRN Amarin Corp Plc\Uk primary H-01 Pharmaceuticals and Biotechnology HG-01 5.67 Bn -209.11 30.46 5.36 Bn
26 ACAD Acadia Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 4.82 Bn 12.66 4.23 3.86 Bn
27 EWTX Edgewise Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.60 Bn -23.34 — 4.60 Bn
28 DFTX Definium Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.26 Bn -12.03 — 4.26 Bn
29 INDV Indivior Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.18 Bn 11.76 3.13 3.95 Bn
30 MANE Veradermics, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 3.99 Bn -46.29 — 3.99 Bn
31 ELVN Enliven Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.94 Bn -46.86 — 3.94 Bn
32 CPRX CATALYST PHARMACEUTICALS, INC. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.85 Bn 17.94 6.45 3.09 Bn
33 TARS Tarsus Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.76 Bn -80.18 6.21 3.31 Bn
34 OGN Organon & Co. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.62 Bn 17.31 0.59 2.49 Bn
35 NAMS NewAmsterdam Pharma Co N.V. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.13 Bn -12.06 439.49 3.13 Bn
36 TRVI Trevi Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.69 Bn -63.86 — 2.69 Bn
37 TAK Takeda Pharmaceutical Co Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 2.64 Bn 4.61 0.06 -3.15 Bn
38 SUPN Supernus Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.55 Bn -29.99 3.24 2.18 Bn
39 HRMY Harmony Biosciences Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.44 Bn 13.70 2.55 1.64 Bn
40 NUVB Nuvation Bio Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.39 Bn -22.09 14.06 2.39 Bn
41 MLYS Mineralys Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.37 Bn -6.77 — 2.37 Bn
42 PVLA Palvella Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.24 Bn -42.20 — 1.92 Bn
43 AUPH Aurinia Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.10 Bn 6.69 6.75 1.66 Bn
44 ETON Eton Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.62 Bn 169.72 16.16 1.59 Bn
45 INVA Innoviva, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.56 Bn 7.94 3.03 0.98 Bn
46 LBRX Lb Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 1.49 Bn -24.55 — 1.49 Bn
47 XERS Xeris Biopharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -85.73 4.39 1.35 Bn
48 HROW Harrow, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.43 Bn -42.63 5.17 1.34 Bn
49 OPK Opko Health, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.24 Bn -32.79 2.11 0.94 Bn
50 KURA Kura Oncology, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.17 Bn -4.91 15.13 1.17 Bn
51 OLMA Olema Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.13 Bn -5.54 — 1.13 Bn
52 PCRX Pacira BioSciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.04 Bn 71.08 1.39 0.79 Bn
53 LXRX Lexicon Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.98 Bn -15.55 23.59 0.79 Bn
54 SGP SpyGlass Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -48.80 — 0.97 Bn
55 DSGN Design Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -11.79 — 0.75 Bn
56 IVA Inventiva S.A. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.89 Bn 9.70 179.22 0.89 Bn
57 VSTM Verastem, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.81 Bn -6.99 9.21 0.67 Bn
58 COLL Collegium Pharmaceutical, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.78 Bn 16.25 0.96 0.63 Bn
59 PHAT Phathom Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -7.91 3.24 0.59 Bn
60 ZVRA Zevra Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.73 Bn 12.60 5.39 0.51 Bn
61 GYRE Gyre Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.68 Bn -36.84 5.70 0.62 Bn
62 AQST Aquestive Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.68 Bn -8.65 12.51 0.68 Bn
63 CRMD CorMedix Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.67 Bn 5.30 1.78 0.41 Bn
64 MPLT MapLight Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -3.13 — 0.63 Bn
65 EOLS Evolus, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -17.65 1.91 0.56 Bn
66 NVCT Nuvectis Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -18.97 — 0.57 Bn
67 SPRY ARS Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -2.52 4.77 0.41 Bn
68 OVID Ovid Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.55 Bn -16.00 348.63 0.43 Bn
69 XFOR X4 Pharmaceuticals, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -5.69 32.37 0.32 Bn
70 PALI Palisade Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -12.40 875.12 0.31 Bn
71 IKT Inhibikase Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.43 Bn -6.63 — 0.27 Bn
72 VTVT vTv Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -87.07 11.24 0.41 Bn
73 ACHV Achieve Life Sciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.37 Bn — — 0.37 Bn
74 VNDA Vanda Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -1.18 1.51 0.16 Bn
75 EBS Emergent BioSolutions Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -1.82 0.42 0.18 Bn
76 SION Sionna Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.29 — 0.32 Bn
77 IMRX Immuneering Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -5.39 — 0.32 Bn
78 TTRX Turn Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -39.36 — 0.30 Bn
79 FULC Fulcrum Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -3.30 — 0.29 Bn
80 ZNTL Zentalis Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -2.05 — 0.29 Bn
81 AKBA Akebia Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -9.01 1.22 0.11 Bn
82 CELG-RI Bristol Myers Squibb Co primary H-01 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.03 0.01 -10.82 Bn
83 SIGA Siga Technologies Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.24 Bn — — 0.08 Bn
84 TNXP Tonix Pharmaceuticals Holding Corp. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.37 7.52 0.22 Bn
85 DERM Journey Medical Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -59.75 3.20 0.19 Bn
86 NERV Minerva Neurosciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -32.50 — 0.21 Bn
87 ACOG Alpha Cognition Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -7.49 15.36 0.16 Bn
88 SLGL Sol-Gel Technologies Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -18.26 106.68 0.14 Bn
89 MCUJF Medicure Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -35.91 8.18 0.19 Bn
90 CRDL Cardiol Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -7.23 — 0.17 Bn
91 LONA LeonaBio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.53 — 0.14 Bn
92 LENZ LENZ Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -1.40 8.46 0.18 Bn
93 MENS Jyong Biotech Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -44.35 — 0.17 Bn
94 BMEA Biomea Fusion, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.54 — 0.14 Bn
95 VANI Vivani Medical, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.73 — 0.11 Bn
96 NTHI Neonc Technologies Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -2.83 — 0.13 Bn
97 AARD Aardvark Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -1.70 — 0.04 Bn
98 VRCA Verrica Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -3.63 3.76 0.10 Bn
99 CPIX Cumberland Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.44 3.25 0.10 Bn
100 RGC Regencell Bioscience Holdings Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn — — 0.09 Bn
101 CGTX Cognition Therapeutics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -2.51 — 0.09 Bn
102 PTHS Pelthos Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -0.78 1.61 0.06 Bn
103 TENX Tenax Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -1.32 — 0.09 Bn
104 MNOV Medicinova Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -6.94 91.29 0.08 Bn
105 PLRX Pliant Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -0.76 — 0.07 Bn
106 PMVP PMV Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.13 — -0.01 Bn
107 CING Cingulate Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -3.11 — 0.07 Bn
108 BOLD Boundless Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -1.00 — 0.06 Bn
109 VERU Veru Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 124.51 — 0.04 Bn
110 GOSS Gossamer Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -0.33 1.05 0.00 Bn
111 KPTI Karyopharm Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.26 0.35 0.05 Bn
112 ANVS Annovis Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.06 — 0.05 Bn
113 CLNN Clene Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.40 222.77 0.05 Bn
114 APRE Aprea Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -3.44 — 0.04 Bn
115 IXHL Incannex Healthcare Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.83 — 0.04 Bn
116 SCLX Scilex Holding Co primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.08 1.20 -0.07 Bn
117 GRCE Grace Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.81 — 0.04 Bn
118 CPHI China Pharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -7.57 8.65 0.03 Bn
119 UG United Guardian Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 14.61 2.95 0.02 Bn
120 ACTU Actuate Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.59 — 0.03 Bn
121 NSRX Nasus Pharma Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -5.64 — 0.03 Bn
122 YARW Yarrow Bioscience, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.27 53.05 0.00 Bn
123 CRVO CervoMed Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.87 79.47 0.03 Bn
124 BYSI BeyondSpring Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.07 — 0.03 Bn
125 TXMD TherapeuticsMD, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -137.01 7.75 0.02 Bn
126 AYTU Aytu Biopharma, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.77 0.42 0.00 Bn
127 ALLR Allarity Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.89 916.46 0.02 Bn
128 ATOS Atossa Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.75 — 0.02 Bn
129 BFRI Biofrontera Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -4.29 0.45 0.02 Bn
130 MIRA Mira Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.55 — 0.01 Bn
131 TVRD Tvardi Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.67 — 0.02 Bn
132 KPRX Kiora Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.47 — 0.02 Bn
133 INTI Inhibitor Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -4.72 — 0.02 Bn
134 CTXR Citius Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.33 2.16 0.02 Bn
135 ANEB Anebulo Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.37 — 0.01 Bn
136 RVPH Reviva Pharmaceuticals Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.82 — 0.01 Bn
137 CALC CalciMedica, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.35 -8.60 -0.01 Bn
138 CURX Curanex Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.95 — 0.00 Bn
139 ADXN Addex Therapeutics Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn 0.05 — 0.01 Bn
140 ACXP Acurx Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.80 — 0.01 Bn
141 TRAW Traws Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.35 — 0.00 Bn
142 PCSA Processa Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.42 — 0.01 Bn
143 PULM Pulmatrix, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.27 — 0.01 Bn
144 TCRT Alaunos Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.99 1,337.11 0.00 Bn
145 CVKD Cadrenal Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.31 — 0.00 Bn
146 BICX BioCorRx Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.64 6.70 0.00 Bn
147 CASIF CASI Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.02 0.12 0.00 Bn
148 SKVI Skinvisible, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -2.25 116.18 0.00 Bn
149 OGEN Oragenics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.22 — 0.00 Bn
150 UPC Universe Pharmaceuticals INC primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — -1,490.23 Bn
151 CANF Can-Fite BioPharma Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.21 5.02 -0.01 Bn
152 MTNB Matinas BioPharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.16 — 0.00 Bn
153 ENSC Ensysce Biosciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
154 SPRC SciSparc Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.05 0.77 0.00 Bn
155 NCEL NewcelX Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.06 — 0.00 Bn
156 JAGX Jaguar Health, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 0.02 -0.01 Bn
157 GLMD Galmed Pharmaceuticals Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — -0.01 Bn
158 CDT CDT Equity Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 — 0.00 Bn
159 GCAN Trafalgar International, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.77 — 0.00 Bn
160 SXTC China SXT Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 0.03 -0.03 Bn
161 CMND Clearmind Medicine Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 — -0.01 Bn
162 AMGN Amgen Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 235.90 Bn 26.98 6.19 221.92 Bn
163 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 187.36 Bn -64.72 6.15 184.18 Bn
164 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 138.87 Bn 31.52 11.03 131.01 Bn
165 REGN Regeneron Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 85.57 Bn 19.77 5.51 77.57 Bn
166 ARGX Argenx Se secondary H-02 Pharmaceuticals and Biotechnology HG-01 63.51 Bn 37.03 12.15 58.32 Bn
167 MRNA Moderna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 58.19 Bn -18.47 26.12 53.05 Bn
168 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.49 Bn 61.05 2.45 38.83 Bn
169 ALNY Alnylam Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 35.38 Bn 45.66 7.36 32.07 Bn
170 ALC Alcon Inc secondary H-06 Medical Devices and Diagnostics HG-02 34.90 Bn 29.30 3.24 33.44 Bn
171 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 32.63 Bn 39.10 3.25 31.35 Bn
172 GEHC GE HealthCare Technologies Inc. secondary H-08 Medical Devices and Diagnostics HG-02 31.13 Bn 15.18 1.46 29.02 Bn
173 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.41 Bn -31.31 24.09 26.25 Bn
174 BNTX BioNTech SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 25.24 Bn -14.81 8.16 11.59 Bn
175 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 25.22 Bn -16.99 2,309.22 25.22 Bn
176 VTRS Viatris Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 19.74 Bn -48.05 1.34 18.85 Bn
177 ZBH Zimmer Biomet Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 18.90 Bn 22.30 2.22 18.49 Bn
178 ASND Ascendis Pharma A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 16.34 Bn -515.88 13.39 15.40 Bn
179 MDGL Madrigal Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.77 Bn -49.44 12.28 14.93 Bn
180 BBIO BridgeBio Pharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 14.58 Bn -21.07 20.45 13.86 Bn
181 BWXT BWX Technologies, Inc. secondary I-39 Clean Energy Equipment IG-10 14.46 Bn 40.61 4.12 13.86 Bn
182 SMMT Summit Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 13.49 Bn — — 12.80 Bn
183 HALO Halozyme Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.92 Bn 31.25 7.77 12.69 Bn
184 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.85 Bn 176.11 3.77 11.98 Bn
185 ARWR Arrowhead Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.33 Bn -45.33 18.42 10.73 Bn
186 GMED Globus Medical Inc secondary H-06 Medical Devices and Diagnostics HG-02 10.60 Bn 19.79 3.37 10.00 Bn
187 GKOS GLAUKOS Corp secondary H-06 Medical Devices and Diagnostics HG-02 10.49 Bn -66.62 17.12 10.38 Bn
188 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.24 Bn -26.84 — 9.48 Bn
189 APGE Apogee Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
190 RDY Dr Reddys Laboratories Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 9.99 Bn 791.40 2.73 9.81 Bn
191 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.68 Bn -45.60 11.07 7.62 Bn
192 PTGX Protagonist Therapeutics, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.58 Bn 86.74 33.97 9.58 Bn
193 PCVX Vaxcyte, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.83 Bn -8.35 — 8.83 Bn
194 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.48 Bn -8.54 51.14 8.12 Bn
195 IMVT Immunovant, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.14 Bn -15.12 — 8.14 Bn
196 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.97 Bn 18.05 9.97 7.29 Bn
197 ABVX Abivax S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.94 Bn -21.34 — 7.94 Bn
198 SYRE Spyre Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.47 Bn -41.73 — 7.47 Bn
199 SRRK Scholar Rock Holding Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.26 Bn -17.97 — 7.26 Bn
200 RYTM Rhythm Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.04 Bn -33.50 29.36 6.71 Bn
201 CGON CG Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.56 Bn -29.28 1,053.93 6.56 Bn
202 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.46 Bn -721.19 4,640.10 6.46 Bn
203 BLCO Bausch & Lomb Corp secondary H-06 Medical Devices and Diagnostics HG-02 6.46 Bn -39.61 1.21 6.08 Bn
204 MIRM Mirum Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.39 Bn -7.43 10.34 5.95 Bn
205 KNSA Kiniksa Pharmaceuticals International, plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.09 Bn 75.51 7.24 5.56 Bn
206 COGT Cogent Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.95 Bn -16.09 — 5.95 Bn
207 XENE Xenon Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.93 Bn -16.37 — 5.93 Bn
208 ORKA Oruka Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.87 Bn — — 4.14 Bn
209 DBVT DBV Technologies S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.86 Bn -33.30 1,167.84 5.69 Bn
210 PTCT Ptc Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.79 Bn 15.14 5.74 3.56 Bn
211 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.76 Bn 29.20 19.82 4.40 Bn
212 AMRX Amneal Pharmaceuticals, Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 5.56 Bn 25.81 1.78 5.43 Bn
213 GRFS Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.33 Bn 20.99 0.32 4.17 Bn
214 CELC Celcuity Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.26 Bn -24.03 — 5.26 Bn
215 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.04 Bn -17.54 — 5.04 Bn
216 RADX Radiopharm Theranostics Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.33 Bn -58.78 20,980.03 4.33 Bn
217 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.18 Bn -8.17 1,159.80 4.18 Bn
218 DNTH Dianthus Therapeutics, Inc. /DE/ secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.11 Bn — — 3.71 Bn
219 VKTX Viking Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.03 Bn -7.53 — 4.03 Bn
220 TLX Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.02 Bn — — 3.73 Bn
221 DYN Dyne Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.01 Bn -7.77 — 4.01 Bn
222 IOVA Iovance Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.91 Bn -18.70 12.03 3.61 Bn
223 RLAY Relay Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.85 Bn -13.48 372.38 3.85 Bn
224 AMLX Amylyx Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.77 Bn -31.05 — 3.77 Bn
225 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.73 Bn -8.11 31.87 3.03 Bn
226 IDYA IDEAYA Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.66 Bn -16.63 15.64 2.83 Bn
227 ABCL AbCellera Biologics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.47 Bn -21.08 52.46 3.47 Bn
228 TNGX Tango Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.38 Bn -33.07 62.89 2.37 Bn
229 IRON Disc Medicine, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.09 Bn -15.33 — 3.09 Bn
230 ARQT Arcutis Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.08 Bn 108.07 6.64 2.84 Bn
231 CLDX Celldex Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.07 Bn -10.00 19,455.07 3.07 Bn
232 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.05 Bn -11.29 593.06 2.53 Bn
233 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.94 Bn -15.60 6.53 2.23 Bn
234 MBX MBX Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.93 Bn -28.11 — 2.93 Bn
235 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.87 Bn -8.41 78.10 2.43 Bn
236 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.62 Bn -80.63 — 2.62 Bn
237 VERA Vera Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.58 Bn -6.44 — 2.58 Bn
238 AXGN Axogen, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 2.58 Bn -174.10 10.25 2.46 Bn
239 CURLF Curaleaf Holdings, Inc. secondary S-09 Tobacco and Cannabis SG-04 2.55 Bn -21.56 1.95 2.46 Bn
240 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.54 Bn -6.61 4.75 2.19 Bn
241 BHC Bausch Health Companies Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 2.46 Bn -2.25 0.23 0.62 Bn
242 NKTR Nektar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -20.53 44.69 1.76 Bn
243 HCM HUTCHMED (China) Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.43 Bn 3.27 3.41 2.43 Bn
244 OCUL Ocular Therapeutix, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.41 Bn -7.97 46.35 2.41 Bn
245 VRDN Viridian Therapeutics, Inc.\DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.40 Bn -6.00 33.74 2.40 Bn
246 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.37 Bn -4.04 — 2.10 Bn
247 SRPT Sarepta Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.34 Bn -17.10 1.19 1.55 Bn
248 XTLB Xtl Biopharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.27 Bn -3,010.83 — 2.27 Bn
249 KOD Kodiak Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.24 Bn -9.24 — 2.24 Bn
250 URGN UroGen Pharma Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.21 Bn -35.52 11.72 2.10 Bn
251 RAPP Rapport Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.21 Bn -16.11 110.49 2.21 Bn
252 FMS Fresenius Medical Care AG secondary H-14 Healthcare Providers HG-04 2.20 Bn 1.85 0.08 0.37 Bn
253 GMAB Genmab A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.18 Bn 0.17 0.34 0.68 Bn
254 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.18 Bn 13.13 4.26 2.05 Bn
255 ZYME Zymeworks Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.15 Bn -14.35 57.96 1.88 Bn
256 PHVS Pharvaris N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.15 Bn -24.18 — 1.78 Bn
257 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -4.99 2,075.13 2.08 Bn
258 XNCR Xencor Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.01 Bn -12.32 19.17 1.63 Bn
259 AGIO Agios Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.97 Bn -4.79 20.04 1.97 Bn
260 STOK Stoke Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.96 Bn -9.43 71.02 1.67 Bn
261 RXRX Recursion Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.94 Bn -3.74 35.38 1.39 Bn
262 VIR Vir Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn -7.68 6.37 1.93 Bn
263 INBX Inhibrx Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.92 Bn -14.42 1,479.94 1.92 Bn
264 LKFT Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.89 Bn 0.01 1.63 1.89 Bn
265 TYRA Tyra Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.88 Bn -12.63 — 1.88 Bn
266 IMCR Immunocore Holdings plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn -102.60 4.31 0.98 Bn
267 SNDX Syndax Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.83 Bn -10.11 7.26 1.28 Bn
268 CMPS COMPASS Pathways plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.79 Bn -4.53 — 1.79 Bn
269 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.78 Bn -212.98 1,035.96 1.78 Bn
270 DMRA Damora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.78 Bn -6.76 — 1.24 Bn
271 GHRS GH Research PLC secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.70 Bn -27.27 — 1.34 Bn
272 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.67 Bn -6.76 4.05 0.96 Bn
273 SEPN Septerna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.66 Bn -119.21 16.83 1.66 Bn
274 ANAB Anaptysbio, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.62 Bn -67.79 8.13 1.33 Bn
275 ATAI AtaiBeckley Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -10.41 527.69 1.60 Bn
276 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.59 Bn -3.44 2.22 1.30 Bn
277 BCAX Bicara Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -8.53 — 1.58 Bn
278 FBRX Forte Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
279 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn -9.11 20.12 1.29 Bn
280 MAZE Maze Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.55 Bn -14.60 77.43 1.55 Bn
281 ANRO Alto Neuroscience, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.53 Bn -18.26 — 1.53 Bn
282 ANIP Ani Pharmaceuticals Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 1.51 Bn 13.96 1.54 1.15 Bn
283 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.48 Bn -9.04 — 1.48 Bn
284 SDGR Schrodinger, Inc. secondary T-27 Vertical Software TG-05 1.48 Bn -27.24 5.71 1.07 Bn
285 REPL Replimune Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -4.90 — 1.45 Bn
286 ALMS Alumis Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.43 Bn -5.89 171.46 0.92 Bn
287 GLUE Monte Rosa Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -9.21 49.37 0.79 Bn
288 ORIC Oric Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.39 Bn -8.85 — 1.39 Bn
289 ABSI Absci Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.39 Bn -11.49 891.17 1.19 Bn
290 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn 80.63 35.82 1.38 Bn
291 CGEM Cullinan Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -6.72 — 1.37 Bn
292 SVRA Savara Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -9.78 — 1.36 Bn
293 VOR Vor Biopharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.35 Bn -1.47 — 1.35 Bn
294 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn -28.10 — 1.13 Bn
295 JANX Janux Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.28 Bn -12.43 53.13 1.28 Bn
296 MNKD Mannkind Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn -28.89 3.20 1.15 Bn
297 JBIO Jade Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.21 Bn -7.93 — 1.21 Bn
298 CLYM Climb Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.17 Bn -20.40 — 1.17 Bn
299 IMTX Immatics N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.15 Bn -4.77 23.66 0.69 Bn
300 MLTX MoonLake Immunotherapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.10 Bn -4.16 — 0.57 Bn